Sumitomo Mitsui Trust Group Inc. Acquires 8,072 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Sumitomo Mitsui Trust Group Inc. raised its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 2.9% during the third quarter, Holdings Channel reports. The institutional investor owned 282,208 shares of the real estate investment trust’s stock after buying an additional 8,072 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Omega Healthcare Investors were worth $11,486,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of OHI. Versant Capital Management Inc bought a new position in shares of Omega Healthcare Investors in the 2nd quarter worth $26,000. UMB Bank n.a. boosted its position in shares of Omega Healthcare Investors by 353.4% in the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 516 shares during the last quarter. DiNuzzo Private Wealth Inc. bought a new position in shares of Omega Healthcare Investors in the 3rd quarter worth $33,000. V Square Quantitative Management LLC boosted its position in shares of Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares during the last quarter. Finally, Covestor Ltd boosted its position in shares of Omega Healthcare Investors by 47.6% in the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock worth $42,000 after purchasing an additional 431 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI opened at $40.03 on Monday. The business’s 50 day moving average price is $40.66 and its two-hundred day moving average price is $36.70. The company has a market cap of $10.81 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.69%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Analysts Set New Price Targets

Several research firms have recently issued reports on OHI. Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Scotiabank raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Truist Financial raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Royal Bank of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research note on Monday, November 11th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.